CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
82 hedge funds and large institutions have $2.64B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 17 closing their positions.
Holders
82
Holders Change
+20
Holders Change %
+32.26%
% of All Funds
1.43%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
37
Increased
18
Reduced
18
Closed
17
Calls
$11.6M
Puts
$2.99M
Net Calls
+$8.61M
Net Calls Change
+$8.61M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$226M |
| 2 |
2
BlackRock
New York
|
$68M |
| 3 |
3
Alkeon Capital Management
New York
|
$67.8M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$33.6M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$9.73M |
Top Sellers
| 1 |
ABG
1
Ally Bridge Group
New York
|
$17.3M |
| 2 |
SFM
2
Sphera Funds Management
Tel Aviv,
Israel
|
$236K |
| 3 |
AG
3
Artal Group
Luxembourg
|
$51.2M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$19.3M |
| 5 |
5
Bank of New York Mellon
New York
|
$9.8M |
